Janney Montgomery Scott
VNDA icon

Janney Montgomery Scott’s Vanda Pharmaceuticals VNDA Stock Holding History

Janney Montgomery Scott’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$950K Sell
155,153
-19,851
-11% -$130K ﹤0.01% 1957
2026
Q1 		$1.21M Sell
175,004
-537
-0.3% -$4.14K ﹤0.01% 1544
2025
Q4 		$1.55M Buy
+175,541
New +$966K ﹤0.01% 1476

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janney Montgomery Scott's VNDA Position: Q2 2026 in Review

Janney Montgomery Scott reduced its Vanda Pharmaceuticals (VNDA) stake by 11% in Q2 2026, selling an estimated $130K and leaving 155,153 shares worth $950K. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

Janney Montgomery Scott first reported a position in VNDA in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.55M in Q4 2025. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Janney Montgomery Scott held 155,153 shares of Vanda Pharmaceuticals worth $950K as of Q2 2026.
  • Janney Montgomery Scott sold 19,851 Vanda Pharmaceuticals shares in Q2 2026, an estimated $130K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1957 holding.
  • Janney Montgomery Scott first reported a position in Vanda Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Janney Montgomery Scott's Vanda Pharmaceuticals position peaked at $1.55M in Q4 2025.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.